Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HER2 is a member of the epidermal growth factor receptor (EGFR) family and plays a crucial role in cell proliferation and growth. It is known for its ability to form homodimers and heterodimers with other ErbB family members, leading to the activation of various signaling pathways. In cancer, particularly breast cancer, HER2 overexpression or amplification is associated with aggressive disease and is targeted by several therapies. The process of HER2 dimerization is critical for its oncogenic activity and is a key target for therapeutic intervention.
Inhibition of HER2 dimerization, Blocking of downstream signaling pathways (e.g., MAPK, PI3K/Akt)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Epidermal Growth Factor Receptor 2 (HER2) dimerization (HER2 dimerization).